Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07763093 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vertically Coronally Advanced Flap Versus Coronally Advanced Flap for Miller Class I Gingival Recession

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Enrollment reduced 19% 16 → 13 participants
See other at-risk trials from University of Medicine and Pharmacy at Ho Chi Minh City

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment reduced: 16 → 13 participants Show 4 more changesShow less
    • Primary completion date changed from estimate of Dec 25, 2026 to Jun 4, 2026
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints revised (6)
    • Study description expanded, about 22 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This randomized controlled clinical trial compares the clinical effectiveness of the Vertically Coronally Advanced Flap (VCAF) and the Coronally Advanced Flap (CAF), both combined with connective tissue graft (CTG) and enamel matrix derivative (EMD), for the treatment of Miller Class I gingival recession. Twenty-four Miller Class I gingival recession defects in 13 patients were randomly assigned in a 1:1 ratio to either the VCAF + CTG + EMD group or the CAF + CTG + EMD group; three patients contributed defects to both groups. Clinical outcomes, including mean root coverage, complete root coverage, recession depth, recession width, keratinized tissue width, gingival thickness, vestibular depth, and esthetic outcomes, are assessed at baseline and throughout a 6-month follow-up period. Three-dimensional digital models obtained from an intraoral scanner are used to evaluate soft tissue changes following treatment. The study is designed to determine whether the VCAF technique provides superior clinical and esthetic outcomes compared with the conventional CAF technique.
Trial Details
NCT Number NCT07763093
Lead Sponsor University of Medicine and Pharmacy at Ho Chi Minh City
Conditions
(from sponsor)		 Gingival Recession
Related terms Gingival Recession
Enrollment 13 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov